Overview
- Visibility actions on May 30, including the Mexican Senate and Mendoza government buildings lit orange, amplified calls from lawmakers and patient groups for concrete policy moves on diagnosis, medicines and funding.
- Mexico’s Senate publicly pressed health authorities to guarantee timely, quality treatments while patient groups warned that monthly therapy costs can reach 80,000–90,000 pesos and that services are concentrated in large cities.
- Peruvian organizations estimate about 3,000 people live with multiple sclerosis in Peru and say only 10–20% access timely treatment, prompting Congress to approve a proposal to mark May 30 as a national day for the disease.
- Argentine coverage highlights wide disagreement over national case counts and persistent diagnostic delays, with surveys and clinicians reporting long waits for imaging, neurologist appointments and treatment starts.
- Experts stress that early diagnosis and disease‑modifying therapies can slow progression but that policy actions such as budget increases, assured drug supply and decentralizing specialist care are needed to turn medical advances into wider patient benefit.